US 11028392
Compositions and methods for inhibiting expression of the ALAS1 gene
granted A61KA61K9/0019A61P
Quick answer
US patent 11028392 (Compositions and methods for inhibiting expression of the ALAS1 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K9/0019, A61P, A61P1/16, A61P25/00